Back

Long-term administration of ranolazine attenuates diastolic dysfunction and adverse myocardial remodeling in a model of heart failure with preserved ejection fraction

21 May 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Moderated Poster Session 4 - Basic Science HFpEF - Heart failure with preserved ejection fraction HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Doctor Antonella De Angelis

University of Campania Luigi Vanvitell, Naples (Italy)

9 More presentations in this session

Presentation thumbnail
HFWM: Raf kinase inhibitor protein modulates interstitial and replacement cardiac fibrosis
Doctor A. Kazakov (Homburg, DE)
Abstract
Presentation thumbnail
Aortic tissue proteomic profiling identifies the osmosignaling pathway components aquaporin-1 and tonicity binding protein as molecular biomarkers and mediators of vascular disease in diabetes
Assistant Professor R. Madonna (Pisa, IT)
Abstract Slides
Presentation thumbnail
Elamipretide (Bendavia, MTP-131) normalizes cGMP levels in left ventricular myocardium of dogs with advanced heart failure
Professor H. Sabbah (Detroit, US)
Abstract Slides
Presentation thumbnail
Role of intercellular adhesion molecule 1 in mediating pro-atherogenic and pro-fibrotic effects of mineralocorticoid receptor activation
Doctor A. Armani (Rome, IT)
Abstract
Presentation thumbnail
Mechanical stretching on cardiac adipose progenitors upregulates sarcomere-related genes
Doctor A. Llucia-Valldeperas (Amsterdam, NL)
Abstract

Access the full session

Session thumbnail
Moderated Poster Session 4 - Basic Science

The Event

Event poster

HEART FAILURE 2016

21 May - 24 May 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources